Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Zhengmei He"'
Autor:
Shandong Tao, Dan Zhou, Lixiao Song, Yuan Deng, Yue Chen, Banghe Ding, Zhengmei He, Chunling Wang, Liang Yu
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives Optimal post-remission treatment for individual favorable and intermediate risk acute myeloid leukemia (AML) patients has not yet been established. Human leukocyte antigen (HLA)-mismatched stem cell microtransplantation (MST), may
Externí odkaz:
https://doaj.org/article/ddaede82bed1408ab51bb859f710bab6
Autor:
Lijuan Zhang, Kankan Chen, Yingying Li, Qiuni Chen, Wenting Shi, Tingting Ji, Hong Tao, Zhengmei He, Chunling Wang, Liang Yu
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective To explore the clinical outcomes and characteristics of TP53-mutated primary myelodysplastic syndromes (MDS).Methods A total of 74 de novo primary MDS patients who were diagnosed and treated in the Department of Hematology of our ho
Externí odkaz:
https://doaj.org/article/a20bd285816d4d699543b0e32d391e5d
Autor:
Yue Chen, Junhui Wang, Jingjing Ma, Linrong Fei, Qiuni Chen, Shandong Tao, Zhengmei He, Chunling Wang, Liang Yu
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground Prognostic nutritional index has been found to be related to the clinical outcomes of patients with cancer. However, its role in myelodysplastic syndromes (MDS) patients is unclear. We aimed to assess the value of nutritional statu
Externí odkaz:
https://doaj.org/article/9304b1c8f4f84da388aa194265b329d0
Autor:
Lijuan Zhang, YuYe Shi, Yue Chen, Shandong Tao, Wenting Shi, Zhengmei He, Kankan Chen, Chunling Wang, Liang Yu
Publikováno v:
Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-9 (2021)
Abstract Background Clonal hematopoiesis (CH) can be found in various myeloid neoplasms (MN), such as myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN), also in pre-MDS conditions. Methods Cytogenetics
Externí odkaz:
https://doaj.org/article/6bd0714c01404f499a1bdb29b7638b34
Autor:
Qiuni Chen, Kankan Chen, Sumei Wang, Lijuan Zhang, Yuye Shi, Shandong Tao, Zhengmei He, Chunling Wang, Liang Yu
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundMyelodysplastic syndromes (MDS) are a heterogeneous spectrum of clonal hematopoietic disorders with varying degrees of cytopenia and morphologic dysplasia. The controlling nutritional status (CONUT) score, an easy-to-use tool for assessing
Externí odkaz:
https://doaj.org/article/52679079a63943b9b2f3d3a7284786b8
Autor:
Qiuni Chen, Yue Chen, Yijing Zhang, Lijuan Zhang, Kankan Chen, Zhengmei He, Chunling Wang, Liang Yu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMyelodysplastic syndromes (MDSs) are a very heterogeneous group of myeloid disorders with high prevalence and risk of developing acute myeloid leukemia. The more accurate risk stratification can provide a better guidance of treatment. The p
Externí odkaz:
https://doaj.org/article/cae27682edea416ab0c9e2d13431f9f0
Autor:
Dongsheng Tang, Yue Chen, Yuye Shi, Hong Tao, Shandong Tao, Quan’e Zhang, Banghe Ding, Zhengmei He, Liang Yu, Chunling Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThis study was conducted in order to study the clinical characteristics, prognostic factors, and treatment outcomes in patients with primary central nervous system lymphoma (PCNSL).Materials and MethodsThe data of a total of 5,166 PCNSL pati
Externí odkaz:
https://doaj.org/article/6d9e8d80268c4c91a5dffdf61ab66a83
Publikováno v:
Platelets, Vol 30, Iss 6, Pp 690-697 (2019)
Rituximab has been frequently used as a second-line treatment for patients with immune thrombocytopenia (ITP). Recently, several studies have proposed low-dose (100 mg or 100mg/m2 per week for 4 weeks) rituximab instead of the standard dose of 375mg/
Externí odkaz:
https://doaj.org/article/5478024008f34af98aa0ffd58e96e70a
Autor:
Yuye Shi, Li-Juan Zhang, Shan-Dong Tao, Yue Chen, Chunling Wang, Zhengmei He, Kan-Kan Chen, Wenting Shi, Liang Yu
Publikováno v:
Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-9 (2021)
Molecular Cytogenetics
Molecular Cytogenetics
Background Clonal hematopoiesis (CH) can be found in various myeloid neoplasms (MN), such as myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN), also in pre-MDS conditions. Methods Cytogenetics is an ind
Autor:
Shandong Tao, Lixiao Song, Dan Zhou, Banghe Ding, Yuan Deng, Yue Chen, Zhengmei He, Chunling Wang, Liang Yu
There was some heterogenity in low or intermediate risk acute myeloid leukemia (AML) stratified by European LeukemiaNet (ELN), the optimal post-remission treatment for an individual favorable and intermediate risk genetics AML patient has not yet bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca3744c944eba0aa16e716000d12933
https://doi.org/10.21203/rs.3.rs-1664364/v1
https://doi.org/10.21203/rs.3.rs-1664364/v1